Jenny Ann Prange

Head of Production, CTO and Co-founder at MUVON Therapeutics AG

Speaker

As co-founder and CTO of MUVON therapeutics AG, Jenny currently leads the production team for the clinical trial Phase II at the Wyss Zurich. Jenny obtained her PhD in Integrative Molecular Medicine from the University of Zurich and gained broad research experience in Switzerland, Germany, France and the US. In 2017, she joined the former Horizon 2020 project MUSIC where she set the foundation for the clean room work through process translation from the research lab into the highly regulated area of GMP and performed the phase I clinical trial productions of MUVON’s cell therapy. Later in 2020, Jenny co-founded MUVON Therapeutics while the clinical phase I was about to finish and is now, tightly involved in the consecutive phase II trial productions.